Charles Bennett

Apr 2, 2024 | ajmc.com | Jason Gibbons |Charles Bennett |Kenneth R. Carson |Gerard F. Anderson

ABSTRACTThe Inflation Reduction Act of 2022 (IRA) allows the Medicare program to negotiate drug prices beginning in 2024. Based on the guidance in the statute, CMS has selected specific data items to use to adjust initial price offers for 10 drugs in the decision-making process. Although much of the data are publicly available, some of these data items will need to be collected directly from drug companies.

Oct 6, 2023 | jamanetwork.com | Martin W. Schoen |Charles Bennett

The role of adjuvant therapy in any malignant neoplasm is to reduce the rate of relapse and, in some patients, increase the chance of cure. Over the last decade, several studies of patients with localized prostate cancer had reported decreased risk of biochemical recurrence or metastasis with addition of adjuvant therapy.

Mar 5, 2023 | accpjournals.onlinelibrary.wiley.com | Jeromie Ballreich |Mariana P. Socal |Charles Bennett |Andrew Xuan

RESEARCH ARTICLE This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1002/phar.2789. Abstract INTRODUCTION The accelerated approval pathway allows for drug approval based on surrogate outcome measures “reasonably likely” to predict clinical benefit.